Evidence map›Paper›PMID 34559498›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2021

Subtypes of luminal breast carcinoma according to the Saint Gallen Consensus in a group of Venezuelan patients

Ángel Fernández-Tortolero, Aldo Reigosa-Yániz

Abstract read
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ángel Fernández-TortoleroCentro de Investigaciones Médicas y Biotecnológicas, Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela; Departamento de Ciencias Fisiológicas, Escuela de Ciencias Biomédicas y Tecnológicas, Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela. angelbiouc@gmail.com.
Aldo Reigosa-YánizCentro de Investigaciones Médicas y Biotecnológicas, Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela. aldo.reigosa@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Breast cancer is the most frequent malignancy in women worldwide. Different intrinsic subtypes have different prognoses and their prevalence varies significantly according to the criteria established in the Saint Gallen Consensus. Objective: To classify the luminal subtypes of breast carcinoma according to Saint Gallen 2009, 2011, 2013, and 2015 consensuses in a group of Venezuelan patients. Materials and methods: We conducted a retrospective study in 209 patients with infiltrating ductal carcinoma of the breast followed up at the Institute of Oncology “Dr. Miguel Pérez Carreno” in Valencia, Venezuela. Results: The distribution of the luminal A and B subtypes changed after the reclassification of the cases according to 2011, 2013, and 2015 Saint Gallen Consensuses. The luminal B subtype was the most common in the study series. Conclusions: With the use of a classification based on the latest Saint Gallen criteria we identified more luminal B tumors. This could contribute to selecting those patients who can avoid adjuvant chemotherapy and/or benefit from the adjuvant hormonal therapy in clinical practice.

Indexed as

Breast NeoplasmsConsensus Statements as TopicErb-b2 Receptor Tyrosine KinasesFemaleHumansPrognosisRetrospective StudiesVenezuelaErb-b2 Receptor Tyrosine KinasesAdenocarcinomabreast neoplasmsVenezuela

Identifiers

PMID34559498
PMCPMC8519592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.